Suppr超能文献

[Ad-VEGF-siRNA抑制血管生成后裸鼠骨肉瘤异种移植瘤的形态学变化]

[Morphological changes in osteosarcoma xenografts in nude mice after inhibiting angiogenesis by Ad-VEGF-siRNA].

作者信息

Wang Jia-Qi, Gao You-Shui, Mei Jiong, Xue Hua-Ming, Wang Shu-Qing, Cai Xuan-Song

机构信息

Department of Orthopedics, Tongji Hospital, Tongji University, Shanghai 200065, P. R. China.

出版信息

Ai Zheng. 2009 Jun;28(6):581-6.

Abstract

BACKGROUND AND OBJECTIVE

Vascular endothelial growth factor (VEGF) is a critical stimulator for angiogenesis of osteosarcoma. This study was to investigate the morphological changes in osteosarcoma xenografts in nude mice after inhibiting angiogenesis by Ad-VEGF-siRNA.

METHODS

The animal model of osteosarcoma xenografts was constructed by subcutaneous inoculation of osteosarcoma MG63 cells into nude mice. The mice were randomly divided into three groups, 15 mice in each group: group A and control groups B and C. The tumor nodules were injected with Ad-VEGF-siRNA in group A, an equal dose of Ad-EGFP and PBS, respectively, in groups B and C. The volume and weight of tumors were measured every two days after injection and the growth curves were drawn. The tumor samples were observed and analyzed using HE staining. Angiogenesis was assessed by immunohistochemical staining using anti-VEGF and CD31 antibodies. The ultrastructure of vasculogenic mimicry (VM) was observed using transmission electron microscopy (TEM).

RESULTS

The mean volume, weight, microvessel density (MVD) and VEGF expression of tumors in Ad-VEGF-siRNA-treated group were significantly lower than those in the control groups. MVD was positively correlated to VEGF expression, with a correlation coefficient of 0.9989. The number of VM was 1.40+/-0.55 in the Ad-VEGF-siRNA group, which was significantly less than those in the two control groups.

CONCLUSION

Ad-VEGF-siRNA could effectively block angiogenesis in osteosarcoma xenografts in nude mice.

摘要

背景与目的

血管内皮生长因子(VEGF)是骨肉瘤血管生成的关键刺激因子。本研究旨在探讨腺病毒介导的VEGF小干扰RNA(Ad-VEGF-siRNA)抑制血管生成后裸鼠骨肉瘤移植瘤的形态学变化。

方法

将骨肉瘤MG63细胞皮下接种于裸鼠,构建骨肉瘤移植瘤动物模型。将小鼠随机分为3组,每组15只:A组和对照组B、C组。A组瘤结节注射Ad-VEGF-siRNA,B、C组分别注射等量的Ad-EGFP和磷酸盐缓冲液(PBS)。注射后每2天测量肿瘤体积和重量并绘制生长曲线。采用苏木精-伊红(HE)染色观察和分析肿瘤样本。用抗VEGF和CD31抗体免疫组化染色评估血管生成情况。用透射电子显微镜(TEM)观察血管生成拟态(VM)的超微结构。

结果

Ad-VEGF-siRNA治疗组肿瘤的平均体积、重量、微血管密度(MVD)和VEGF表达均显著低于对照组。MVD与VEGF表达呈正相关,相关系数为0.9989。Ad-VEGF-siRNA组VM数量为1.40±0.55,明显少于两个对照组。

结论

Ad-VEGF-siRNA可有效阻断裸鼠骨肉瘤移植瘤的血管生成。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验